515 related articles for article (PubMed ID: 25431268)
1. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain.
Vazquez-DeRose J; Schwartz MD; Nguyen AT; Warrier DR; Gulati S; Mathew TK; Neylan TC; Kilduff TS
Brain Struct Funct; 2016 Mar; 221(2):923-40. PubMed ID: 25431268
[TBL] [Abstract][Full Text] [Related]
2. Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep.
Schwartz MD; Nguyen AT; Warrier DR; Palmerston JB; Thomas AM; Morairty SR; Neylan TC; Kilduff TS
eNeuro; 2016; 3(2):. PubMed ID: 27022631
[TBL] [Abstract][Full Text] [Related]
3. The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems.
Parks GS; Warrier DR; Dittrich L; Schwartz MD; Palmerston JB; Neylan TC; Morairty SR; Kilduff TS
Neuropsychopharmacology; 2016 Mar; 41(4):1144-55. PubMed ID: 26289145
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain.
Murillo-Rodriguez E; Liu M; Blanco-Centurion C; Shiromani PJ
Eur J Neurosci; 2008 Sep; 28(6):1191-8. PubMed ID: 18783368
[TBL] [Abstract][Full Text] [Related]
5. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.
Gerashchenko D; Salin-Pascual R; Shiromani PJ
Brain Res; 2001 Sep; 913(1):106-15. PubMed ID: 11532254
[TBL] [Abstract][Full Text] [Related]
6. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
[TBL] [Abstract][Full Text] [Related]
7. Lesion of the basal forebrain cholinergic neurons attenuates sleepiness and adenosine after alcohol consumption.
Sharma R; Sahota P; Thakkar MM
J Neurochem; 2017 Sep; 142(5):710-720. PubMed ID: 28444769
[TBL] [Abstract][Full Text] [Related]
8. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
Thakkar MM; Ramesh V; Strecker RE; McCarley RW
Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
[TBL] [Abstract][Full Text] [Related]
9. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation.
Beuckmann CT; Ueno T; Nakagawa M; Suzuki M; Akasofu S
Sleep; 2019 Jun; 42(6):. PubMed ID: 30923834
[TBL] [Abstract][Full Text] [Related]
10. Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect.
Liu ZW; Gao XB
J Neurophysiol; 2007 Jan; 97(1):837-48. PubMed ID: 17093123
[TBL] [Abstract][Full Text] [Related]
11. Parallel Arousal Pathways in the Lateral Hypothalamus.
Heiss JE; Yamanaka A; Kilduff TS
eNeuro; 2018; 5(4):. PubMed ID: 30225361
[TBL] [Abstract][Full Text] [Related]
12. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
España RA; Baldo BA; Kelley AE; Berridge CW
Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
[TBL] [Abstract][Full Text] [Related]
13. Activation of the basal forebrain by the orexin/hypocretin neurones.
Arrigoni E; Mochizuki T; Scammell TE
Acta Physiol (Oxf); 2010 Mar; 198(3):223-35. PubMed ID: 19723027
[TBL] [Abstract][Full Text] [Related]
14. Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial.
Neylan TC; Richards A; Metzler TJ; Ruoff LM; Varbel J; O'Donovan A; Sivasubramanian M; Motraghi T; Hlavin J; Batki SL; Inslicht SS; Samuelson K; Morairty SR; Kilduff TS
Sleep; 2020 Oct; 43(10):. PubMed ID: 32303763
[TBL] [Abstract][Full Text] [Related]
15. The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats.
Morairty SR; Wilk AJ; Lincoln WU; Neylan TC; Kilduff TS
Front Neurosci; 2014; 8():3. PubMed ID: 24550767
[TBL] [Abstract][Full Text] [Related]
16. Orexins/hypocretins excite basal forebrain cholinergic neurones.
Eggermann E; Serafin M; Bayer L; Machard D; Saint-Mleux B; Jones BE; Mühlethaler M
Neuroscience; 2001; 108(2):177-81. PubMed ID: 11734353
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypocretin-1 in 192-IgG-saporin-lesioned rats.
Blanco-Centurion CA; Shiromani A; Winston E; Shiromani PJ
Eur J Neurosci; 2006 Oct; 24(7):2084-8. PubMed ID: 17067305
[TBL] [Abstract][Full Text] [Related]
18. The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions.
Kalinchuk AV; McCarley RW; Stenberg D; Porkka-Heiskanen T; Basheer R
Neuroscience; 2008 Nov; 157(1):238-53. PubMed ID: 18805464
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of lateral hypothalamic glutamate and acetylcholine efflux by nicotine: implications for mechanisms of nicotine-induced activation of orexin neurons.
Pasumarthi RK; Fadel J
J Neurochem; 2010 May; 113(4):1023-35. PubMed ID: 20236223
[TBL] [Abstract][Full Text] [Related]
20. A1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats.
Rai S; Kumar S; Alam MA; Szymusiak R; McGinty D; Alam MN
Neuroscience; 2010 Apr; 167(1):40-8. PubMed ID: 20109537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
